Glial fibrillary acidic protein (GFAP) is a class III intermediate filament (IF) protein and is used as a marker to distinguish astrocytes from other glial cells during development. GFP may play a role in maintaining mechanical strength and shape in astrocytes but its exact function still remains mostly uncharacterized. Mutations in GFAP are well-known to cause Alexander disease (1), but recent studies have shown that GFAP may be a useful marker in spinal astrocytoma. A variant of GFAP, GFAP-gamma was shown to be upregulated in patients with high grade spinal cord astrocytoma compared to normal tissues (2).



-Immunofluorescence-NBP1-97921-img0002.jpg)
-Immunohistochemistry-Paraffin-NB100-74340-img0005.jpg)
-Western-Blot-NB300-614-img0002.jpg)
